Can novel therapeutics halt the amyloid cascade?
Journal Information
Full Title: Alzheimers Res Ther
Abbreviation: Alzheimers Res Ther
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Competing interests NDP has a senior fellowship at the Alzheimer Center VUmc partly supported by Vereniging AEGON. PJV is the recipient of a grant award from Bristol-Myers Squibb and is a consultant to Elan, Wyeth, Bristol-Myers Squibb, Myriad Pharmaceuticals and Danone Research. PS has consulted for Elan-Wyeth, Bristol-Myers Squibb, Myriad Pharmaceuticals, and Danone Research."
"The study was in part funded by the European Commission within the sixth framework programme (LSHB-2007-037670, to PJV). NDP has a senior fellowship at the Alzheimer Center VUmc partly supported by Vereniging AEGON. PJV is the recipient of a grant award from Bristol-Myers Squibb and is a consultant to Elan, Wyeth, Bristol-Myers Squibb, Myriad Pharmaceuticals and Danone Research. PS has consulted for Elan-Wyeth, Bristol-Myers Squibb, Myriad Pharmaceuticals, and Danone Research."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025